Literature DB >> 28152660

Diagnosis and Treatment of ADHD in the United States: Update by Gender and Race.

Kathleen A Fairman1, Alyssa M Peckham1, David A Sclar1.   

Abstract

Objective: The aim of this article is to update ADHD diagnosis/treatment trends by age, gender, and race. Method: National Ambulatory Medical Care Survey data were obtained for 2008-2009 to 2012-2013. Physician office visits including ADHD diagnosis and pharmacotherapy were measured per 1,000 population and per 1,000 office visits overall, and by demographic group. Logistic regression models controlled for demographics, psychiatric comorbidities, insurance type, and time period. Interactions of time, demographics, comorbidities, and insurance type were tested.
Results: Diagnoses of ADHD increased by 36% in adults and 18% in youth, and diagnosis + drug by 29% in female and 10% in male youths. ADHD diagnosis was 77% less likely among Black than White adults but 24% more likely among Black than White youths in 2012-2013. Conduct disorder (CD) in youths multiplied odds of diagnosis + drug by 3.31; interaction of Black race × CD by 3.78.
Conclusion: Upward trends in ADHD diagnosis and treatment have continued but vary markedly by group. Studies of undertreatment/overtreatment are needed.

Entities:  

Keywords:  ADHD; epidemiology; gender; prescription prevalence; race

Mesh:

Year:  2017        PMID: 28152660     DOI: 10.1177/1087054716688534

Source DB:  PubMed          Journal:  J Atten Disord        ISSN: 1087-0547            Impact factor:   3.256


  7 in total

1.  Lifetime prevalence and age-of-onset of mental disorders in adults from the Argentinean Study of Mental Health Epidemiology.

Authors:  Alfredo H Cía; Juan Carlos Stagnaro; Sergio Aguilar Gaxiola; Horacio Vommaro; Gustavo Loera; María Elena Medina-Mora; Sebastían Sustas; Corina Benjet; Ronald C Kessler
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2018-02-19       Impact factor: 4.328

2.  Diagnoses of Cardiovascular Disease or Substance Addiction/Abuse in US Adults Treated for ADHD with Stimulants or Atomoxetine: Is Use Consistent with Product Labeling?

Authors:  Kathleen A Fairman; Lindsay E Davis; Alyssa M Peckham; David A Sclar
Journal:  Drugs Real World Outcomes       Date:  2018-03

Review 3.  Psychostimulants As Cognitive Enhancers in Adolescents: More Risk than Reward?

Authors:  Kimberly R Urban; Wen-Jun Gao
Journal:  Front Public Health       Date:  2017-09-26

4.  High-risk opioid prescribing trends in the outpatient setting prior to issuance of federal guidance.

Authors:  Alyssa M Peckham; Kathleen A Fairman; Gina Awanis; Nicole K Early
Journal:  Prev Med Rep       Date:  2019-05-17

5.  Development of coordination and muscular fitness in children and adolescents with parent-reported ADHD in the German longitudinal MoMo Study.

Authors:  Elke Opper; Olga Kunina-Habenicht; Doris Oriwol; Anke Hanssen-Doose; Janina Krell-Roesch; Robert Schlack; Annette Worth; Alexander Woll
Journal:  Sci Rep       Date:  2022-02-08       Impact factor: 4.379

6.  What's race got to do with it? Informant rating discrepancies in neuropsychological evaluations for children with ADHD.

Authors:  Danielle Wexler; Rod Salgado; Allison Gornik; Rachel Peterson; Alison Pritchard
Journal:  Clin Neuropsychol       Date:  2021-07-08       Impact factor: 3.535

7.  Trends in the Prevalence and Incidence of Attention-Deficit/Hyperactivity Disorder Among Adults and Children of Different Racial and Ethnic Groups.

Authors:  Winston Chung; Sheng-Fang Jiang; Diana Paksarian; Aki Nikolaidis; F Xavier Castellanos; Kathleen R Merikangas; Michael P Milham
Journal:  JAMA Netw Open       Date:  2019-11-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.